The more pertinent observation, the one that clings to the discerning eye, is that the stock still languishes some distance from its former glory. A circumstance, I submit, that makes it… interesting. Particularly for those of us who find ourselves contemplating the possibility – and honestly, it’s only a matter of time – of a rather unpleasant bear market. Allow me to provide a rationale, in three sober measures.
The stock, akin to a prodigal son boasting of yields surpassing 15%, raises a question worthy of Aristotle’s inquiries: Can we expect brighter days ahead? Shall the dividend—a reward for our patience—survive the cataclysm of the second quarter?
The business, a relic of industrial might, had grown weary. Its growth, once a steady rhythm, had faltered into a hesitant waltz. Investors, their hopes frayed by years of decline, watched as the stock’s descent mirrored the fading glow of a sunset over a forgotten town. The prospect of a breakup, murmured like a secret in a dusty library, hinted at a desperate attempt to resurrect the corpse of a brand that had outlived its relevance. Yet, in the quiet corners of corporate boardrooms, there lingered a faint possibility that the company’s sauces and spreads—those humble staples—might yet unlock a forgotten promise of growth, while its processed meats, shrouded in the shadow of health fears, faced an uncertain fate.
First, roll out the red carpet for the lead star—AI!
This titan, American Express (AXP), commands a formidable 21.6% stake held by the oracle himself, Warren Buffett. Having surged an astounding 217% over the past five years—as of July 23—it stands as a paragon of resilience in turbulent times.
But before you toss your shares into the metaphorical void like so much discarded bubble wrap, consider this: selling now could be as ill-advised as trying to read the terms and conditions of a software update while simultaneously eating a sandwich. And if you’re contemplating buying? Well, let’s just say there are reasons to believe this glass might not only be half-full but also bubbling over with fizzy potential.
Now, sure, the stock is strutting around at dizzying heights, leaving many scratching their heads over whether it’s really worth the price of admission. But like that charming yet utterly disastrous partner at a wedding, you just can’t help but pay attention to Visa’s complexities.
When one thinks of AI stocks, Nvidia, that dashing chipmaker with a twinkle in its GPU, reigns supreme. One might imagine the investor, somewhat befuddled by the labyrinthine corridors of silicon valleys, receiving a nudge in the right direction by this most amiable of guides. For you see, GPUs—those delightful little workhorses—are the lifeblood of AI’s grand experiment. They train models with the enthusiasm of a terrier after a postman and deploy them with the precision of a Swiss watchmaker. Without them, the entire affair would collapse into a rather unsightly heap of ones and zeroes.
If June was but a prelude, July has become the grand ballroom of Wall Street’s affections. Consider the following exchanges:
Since its initial public offering in 2000, Intuitive Surgical has delivered returns exceeding 25,000%. Such figures are the stuff of legends—or so one might think. But today, the stock hovers in the middle of its 52-week range, neither rising to meet the applause of investors nor collapsing under the weight of despair. Is this stagnation a temporary malaise, or does it signal something more profound?